It looks like your are using Internet Explorer.
Unfortunately, Internet Explorer is an outdated browser and we do not currently support it fully. You are seeing a limited view of the meeting details below.
To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.
Pharmacies in the US as a Distribution Model for DTx
The large pharmacy chains model in the US presents pharmacies as a promising distribution channel for Digital Therapeutics (DTx). Pharmacists, as trusted healthcare professionals, have a long-standing relationship with the local patient community and access to a wide range of patients, making pharmacies a potentially attractive target for DTx companies seeking to boost adoption of both prescription and over-the-counter (OTC) DTx products.
However, despite the benefits, the viability of this model is still uncertain and requires further exploration. There are many challenges that must be addressed. How can we overcome those challenges and establish a clearer path for this model to succeed? Join this meeting to discuss about:
- Pros and cons of using pharmacies as a distribution model for DTx in the US. How can pharmacists act as a patient activator and give support along the digital treatment? How to scale this model?
- Meeting pharmacists’ needs. DTx solutions have been designed with the patient and physician in mind, hence pharmacists’ needs are rarely met. How can we include pharmacists at the center of the DTx business model?
- Incentives for pharmacists. How can we work on financial incentive models for pharmacies? What should these models look like?
- Beyond OTC DTx: the potential of pharmacists to become authorized prescribers. How could the industry work together to give pharmacies the authority to prescribe Prescription DTx (PDT) solutions?
- Awareness and training for pharmacy staff. What type of training do pharmacy staff need to effectively counsel and support patients using DTx solutions? What support would the pharmacy's staff need? How can we leverage conferences and pharmacists’ associations to address the knowledge gap and promote DTx?
- Integration with EHR systems. When pharmacies are the DTx prescribers, how can we ensure the data is well integrated with the EHR so then physicians can use it for decision-making?
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.
An invite invite link has been sent to you if you do not already have a HealthXL account.
An invite link will be sent to your inbox.
Pharmacies in the US as a Distribution Model for DTx
Pharmacies in the US as a Distribution Model for DTx
Join this HealthXL Event today:
Participate in this Digital Health Sprint in order to:
- Deep dive into a topic over 2 focused sessions.
- Engage with a small group of 10 global thought-leaders throughout.
- This sprint is outcome-focused: HealthXL and participants create exclusive outputs.
- Grow your network with our break out sessions.
You actively participate in this discussion. Spaces are limited to 8 - 12 people, allowing you to focus on quality in-depth conversations.
Don't miss your opportunity to connect with senior leaders to shape the future of digital health. Because only if you are prepared now can you lead the future.
The large pharmacy chains model in the US presents pharmacies as a promising distribution channel for Digital Therapeutics (DTx). Pharmacists, as trusted healthcare professionals, have a long-standing relationship with the local patient community and access to a wide range of patients, making pharmacies a potentially attractive target for DTx companies seeking to boost adoption of both prescription and over-the-counter (OTC) DTx products.
However, despite the benefits, the viability of this model is still uncertain and requires further exploration. There are many challenges that must be addressed. How can we overcome those challenges and establish a clearer path for this model to succeed? Join this meeting to discuss about:
- Pros and cons of using pharmacies as a distribution model for DTx in the US. How can pharmacists act as a patient activator and give support along the digital treatment? How to scale this model?
- Meeting pharmacists’ needs. DTx solutions have been designed with the patient and physician in mind, hence pharmacists’ needs are rarely met. How can we include pharmacists at the center of the DTx business model?
- Incentives for pharmacists. How can we work on financial incentive models for pharmacies? What should these models look like?
- Beyond OTC DTx: the potential of pharmacists to become authorized prescribers. How could the industry work together to give pharmacies the authority to prescribe Prescription DTx (PDT) solutions?
- Awareness and training for pharmacy staff. What type of training do pharmacy staff need to effectively counsel and support patients using DTx solutions? What support would the pharmacy's staff need? How can we leverage conferences and pharmacists’ associations to address the knowledge gap and promote DTx?
- Integration with EHR systems. When pharmacies are the DTx prescribers, how can we ensure the data is well integrated with the EHR so then physicians can use it for decision-making?
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.
Participants
Participants
Mark Thomas
Healthcare Consultant, ProspHire
Eugene Borukhovich
COO & Co-Founder of YourCoach.Health
Cathy Zaremba
Director of Product Marketing, BrightInsight
Jock Thompson
Chief Revenue Officer, Miku
Ashley Pippin
Director, Digital Product Delivery, Novartis Biome
Benjamin Alouf
Chief Medical Officer, Limbix
Howard Greenman
Vice President, Business Development, Akili Interactive
John Poikonen
Director of Clinical Informatics, AmalgamRx
Summer Robinson
Market Access Reimbursement, Pear Therapeutics
Up to 12
Pharmacies in the US as a Distribution Model for DTx
The large pharmacy chains model in the US presents pharmacies as a promising distribution channel for Digital Therapeutics (DTx). Pharmacists, as trusted healthcare professionals, have a long-standing relationship with the local patient community and access to a wide range of patients, making pharmacies a potentially attractive target for DTx companies seeking to boost adoption of both prescription and over-the-counter (OTC) DTx products.
However, despite the benefits, the viability of this model is still uncertain and requires further exploration. There are many challenges that must be addressed. How can we overcome those challenges and establish a clearer path for this model to succeed? Join this meeting to discuss about:
- Pros and cons of using pharmacies as a distribution model for DTx in the US. How can pharmacists act as a patient activator and give support along the digital treatment? How to scale this model?
- Meeting pharmacists’ needs. DTx solutions have been designed with the patient and physician in mind, hence pharmacists’ needs are rarely met. How can we include pharmacists at the center of the DTx business model?
- Incentives for pharmacists. How can we work on financial incentive models for pharmacies? What should these models look like?
- Beyond OTC DTx: the potential of pharmacists to become authorized prescribers. How could the industry work together to give pharmacies the authority to prescribe Prescription DTx (PDT) solutions?
- Awareness and training for pharmacy staff. What type of training do pharmacy staff need to effectively counsel and support patients using DTx solutions? What support would the pharmacy's staff need? How can we leverage conferences and pharmacists’ associations to address the knowledge gap and promote DTx?
- Integration with EHR systems. When pharmacies are the DTx prescribers, how can we ensure the data is well integrated with the EHR so then physicians can use it for decision-making?
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.
HealthXL Meetings
HealthXL Digital Health Meetings connect you with senior leaders around the world to discuss, solve and support each other.
Your time is valuable. This is why each Digital Health Meeting is limited to 75 minutes - long enough for engaging discussions but short enough to fit into your busy weekly schedule.
Digital Health Meetings are fully interactive and promote conversation - be ready to talk!
HealthXL Digital Health Meetings are not webinars. There is no audience, no recordings and no hiding behind a screen. Discuss, reflect and share learnings in a private but interactive group.
No long speeches, no wait, no travel. Take a productive deep dive into different digital health topics in just 75 minutes - perfect for when you’re on a break.
Join a community of gamechangers in digital health. With a HealthXL membership, you meet like-minded people with unique perspectives. And as a HealthXL member, you get access to regular Digital Health Meetings.
Stay informed on the HealthXL Communities Hub. Connect with your peers, receive notifications about the latest interactive Meetings, get curated digital health news and access industry reports, insights, shared resources and more.
Join from anywhere
No need for a high end laptop to display fancy 3D personas or interactive conference rooms: All you need is a working camera and an internet-ready device to join.
The world of Digital Health in one Hub
Be ready for the future of Digital Health and join a community of passionate leaders, innovators and gamechangers.
As a HealthXL member, you get access to a wealth of information, resources and connections. From daily curated news by our in-house expert team to industry reports each retailing at €2000 - you have the world of Digital Health right at your fingertips.
Our community is growing fast. Don’t miss out on your opportunity to lead the future.
News
Your Digital Health Corner
All Posts%20(1).png)
.png)
%20(2).png)
Beyond Patient Engagement: Why Collaboration is Essential in Health Tech
Read More
Frequently Asked Questions
What is a HealthXL Digital Health Meeting?
HealthXL Digital Health Meetings are private group meetings limited to a maximum of 10 people across different demographic and stakeholder groups. They are not webinars, but participant-led group meetings to allow you to explore every facet of digital health with peers.
How can I become a member of the Digital Health Community?
We invite you to create a free account on our Community Hub to have a look behind the curtains. We'd love to show you the platform in a personal call. Click here to schedule a free session with a member of our team.
When can I access the Meeting recording?
Our Meetings are all about honest, open discussions. This is why we do not record our them. After each Meeting, if you were a participant, you will receive a link to the key takeaways; a short summary of the Meeting.
I am participating in this meeting, but can't attend anymore. Can I cancel it?
It can always happen that you cannot attend meetings due to unforeseen reasons. Due to the small group size, even missing one person can be disruptive. We'd like to ask all participants to inform us with at least 48 hours notice or suggest a suitable replacement for themselves.
Pharmacies in the US as a Distribution Model for DTx
Pharmacies in the US as a Distribution Model for DTx
Pharmacies in the US as a Distribution Model for DTx
The large pharmacy chains model in the US presents pharmacies as a promising distribution channel for Digital Therapeutics (DTx). Pharmacists, as trusted healthcare professionals, have a long-standing relationship with the local patient community and access to a wide range of patients, making pharmacies a potentially attractive target for DTx companies seeking to boost adoption of both prescription and over-the-counter (OTC) DTx products.
However, despite the benefits, the viability of this model is still uncertain and requires further exploration. There are many challenges that must be addressed. How can we overcome those challenges and establish a clearer path for this model to succeed? Join this meeting to discuss about:
- Pros and cons of using pharmacies as a distribution model for DTx in the US. How can pharmacists act as a patient activator and give support along the digital treatment? How to scale this model?
- Meeting pharmacists’ needs. DTx solutions have been designed with the patient and physician in mind, hence pharmacists’ needs are rarely met. How can we include pharmacists at the center of the DTx business model?
- Incentives for pharmacists. How can we work on financial incentive models for pharmacies? What should these models look like?
- Beyond OTC DTx: the potential of pharmacists to become authorized prescribers. How could the industry work together to give pharmacies the authority to prescribe Prescription DTx (PDT) solutions?
- Awareness and training for pharmacy staff. What type of training do pharmacy staff need to effectively counsel and support patients using DTx solutions? What support would the pharmacy's staff need? How can we leverage conferences and pharmacists’ associations to address the knowledge gap and promote DTx?
- Integration with EHR systems. When pharmacies are the DTx prescribers, how can we ensure the data is well integrated with the EHR so then physicians can use it for decision-making?
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.
Join this group of peers and get a feel of what it's like to belong to a community of digital health gamechangers.
All meetings are limited to 10 people to allow for honest discussions, so apply fast or become a HealthXL member and get priority access to all meetings, latest industry reports and and much more.
Frequently asked questions:
What are HealthXL Virtual Meetings?
HealthXL Virtual Meetings are private group meetings limited to 10 people across different demographic and stakeholder groups. For 75 minutes, you take a deep dive into your chosen topic and explore it from different angles. Virtual Meetings are not webinars: There is no audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And through our Community Hub, you stay up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.
How can I connect with other digital health leaders?
HealthXL brings together gamechangers of digital health to support honest discussions in small, private groups. In our Community Hub, for which you can register for free, you can follow a wide range of communities across telehealth, digital therapeutics, patient engagement and more. As a full HealthXL member, you also get access to curated news, the latest insights and an expert network to connect with. Join exclusive virtual meetings to exchange strategies, viewpoints and learnings with members from like-minded yet diverse stakeholder groups.
What are the benefits of being a HealthXL community member?
As member of HealthXL, you join a community of digital health thought leaders, innovators and game changers around the world. With your membership, you get access to hundreds of insights, reports and resources. You can browse a database with over 90k healthcare organizations and view their active strategic partnerships, commercial relationships, latest funding rounds and research. Through our in-house curated digital health newsfeed, you stay informed on the most impactful news and you can regularly meet with members to share learnings, discuss the latest developments and connect with peers of different demographical stakeholder groups. Contact us today to find out about pricing options.
Through focus groups, we bring together 6-10 thought leaders and industry stakeholders in a series of virtual meetings to collaborate around a defined topic. Each meeting gives the group the opportunity to examine, analyze and collaborate with one another around a digital health topic as well as produce a shareable result.
